Use access key #2 to skip to page content.
$58.04 -0.30 (-0.51%)
8/21/2008 4:00 PM

Abbott Laboratories (ABT)

CAPS Rating:
****

Principal business is the discovery, development, manufacture and sale of a broad and diversified line of health care products. Company has four segments: Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating ABT

Add Stock to Watchlist

What the Community Thinks

Total Members

796 Outperforms
61 Underperforms
 

All-Stars

231 Outperforms
9 Underperforms
 

Wall Street

20 Outperforms
0 Underperforms
 

Members bullish on ABT are also bullish on:

Members bearish on ABT are also bearish on:

Ticker Tags

Medical Device (43), Dividend (202), Drug Manufacturers - Major (27), Illinois (19), Mega Cap (145), Multinational Company (16), S&P 500 (480), Big Pharma (12), Chicago (31)
Suggest a tag

Abbott Laboratories At A Glance

Current Price: $58.04
Last Trade Time: 8/21/2008 4:00 PM
Open: $57.95
Previous Close: $58.34
Daily Range: $57.51 - $58.14
52-Week Range: $50.09 - $61.09
Volume: 3,815,302
Market Cap: $89.93B
P/E Ratio: 21.45
Compare Our Special Broker Offers!

Stock Trends

ABT VS S&P 500 (SPY)

ABT 12 month chart vs. S&P

News & Discussion Boards

Other News Headlines for ABT

More Headlines...

Top Bull Pitch

Recs

1

Abbott Laboratories (ABT)

Avatar lorted1956 (< 20) Submitted: 2/22/08 2:50 PM

Abbott has inherited the VI business from Boston Scientific ( Stents etc.. )


They are a solid player overall good performer.


The only problem could be themselves.


They are very slow in responding to the customers needs.


Playing in the Cardiology arena...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

Recs

2

Abbott Laboratories (ABT)

Avatar boiseidfool (78.33) Submitted: 3/03/07 9:35 AM

Idaho has filed a lawsuit that alleges Abbott Laboratories falsified wholesale drug prices and that the state has overpaid Medicaid reimbursements because of the manipulated drug prices. In the complaint, the Idaho attorney general's office says the prices charged to hospitals and pharmacies for Ab...More

Replies: 0 | Reply | Permalink

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 126 :   1 2 3 4 5 Next » Jump to page:

Recs

0

 (ABT)

Avatar 881500 (22.17) Submitted: 7/31/08 7:50 AM : Outperform Start Price: $56.59 ABT Score: 2.25

i got it, i reccomend it, you buy it, the price goes up, I love this site.


zacks buy rank 3


target 65.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar JUT8407 (96.32) Submitted: 7/18/08 1:08 PM : Outperform Start Price: $57.38 ABT Score: -2.97

the entire health care & Pharmaceutical sector very undervalued. has a very good pipeline and also has many products available today producing great revenues for the company. With an aging population a drug for just about anything, this will be a good/safe bet.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar swordbop (20.18) Submitted: 7/15/08 9:32 AM : Outperform Start Price: $56.76 ABT Score: -2.90

Outperform: Likely to be shelter from greater market malaise.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar mitleg (< 20) Submitted: 7/14/08 2:14 PM : Outperform Start Price: $56.58 ABT Score: -1.27

This stock looks a little pricey with a pe of 22.5 and a peg of 1.5. Yet, this could be a safe place to park some funds with the current market volatility showing no end in sight. Like JNJ it is a one stop shop for all things medical. They have pharma, nutritionals, and medical supplies. I can see slow price appreciation upcoming.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (ABT)

Avatar caseykimma (92.78) Submitted: 7/10/08 11:20 PM : Outperform Start Price: $56.81 ABT Score: -1.31

big pharma seems to be making a move up, at least for the short term...try to capture a few points here, if not a few more

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 126 :   1 2 3 4 5 Next » Jump to page:

Wall Street

Results 1 - 20 of 20  

picks per page. CHANGE Expand All Pitches

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackLeerinkSwan 98.15 06/23/08 Outperform NS $53.13+9.23%-3.25%+12.48
TrackUBS 96.60 05/09/08 Outperform NS $50.91+14.01%-7.66%+21.67
TrackWachovia 75.04 03/20/08 Outperform NS $53.97+7.53%-1.73%+9.26
TrackStanfordRes 83.82 10/09/07 Outperform NS $53.69+8.10%-17.87%+25.97
TrackEdwardOwens 99.19 09/30/07 Outperform NS $52.32+10.93%-16.24%+27.17 Toggle the visibility of 60-Second Pitch and replies
TrackSnow 95.14 09/30/07 Outperform NS $52.32+10.93%-16.24%+27.17 Toggle the visibility of 60-Second Pitch and replies
TrackDodgeCox 98.98 09/30/07 Outperform NS $52.32+10.93%-16.24%+27.17 Toggle the visibility of 60-Second Pitch and replies
TrackJohnKeeley 96.59 09/30/07 Outperform NS $52.32+10.93%-16.24%+27.17 Toggle the visibility of 60-Second Pitch and replies
TrackRichAster 97.12 09/30/07 Outperform NS $52.32+10.93%-16.24%+27.17 Toggle the visibility of 60-Second Pitch and replies
TrackBRogers 94.84 09/30/07 Outperform NS $52.32+10.93%-16.24%+27.17 Toggle the visibility of 60-Second Pitch and replies
TrackScottBleier 31.05 07/20/07 Outperform 3M $51.59+12.50%-16.74%+29.24
TrackZacks 91.22 05/29/07 Outperform 3M $54.94+5.64%-16.05%+21.69 Toggle the visibility of 60-Second Pitch and replies
TrackLehmanBros 90.90 05/07/07 Outperform NS $57.16+1.54%-15.34%+16.87
TrackGaryBSmith 62.49 03/31/07 Outperform 3W $54.12+7.25%-10.00%+17.25
TrackMichaelSivy 94.70 03/20/07 Outperform 1Y $54.01+7.46%-9.34%+16.80
TrackMatrix 94.39 03/01/07 Outperform NS $51.83+11.98%-8.28%+20.26
TrackRBCCapMkts 94.50 01/25/07 Outperform NS $51.01+13.78%-11.06%+24.84
TrackAGEdwards 93.61 01/22/07 Outperform NS $51.30+13.13%-10.67%+23.81
TrackJimCramer 81.38 12/06/06 Outperform 3W $46.30+25.36%-9.82%+35.19
TrackBofASec 97.33 09/05/06 Outperform NS $46.84+23.92%-2.82%+26.74
TrackRochdale 20.17 08/16/06 Outperform NS $47.25+22.83%-0.11%+22.94

Results 1 - 20 of 20  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners